Go to deals
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady and based in Nijmegen, the Netherlands, ScreenPoint Medical develops and markets innovative machine learning solutions to improve breast cancer screening and diagnosis. With its market-leading AI solution Transpara, ScreenPoint Medical supports radiologists in evaluating mammograms to detect breast cancer and allows them to improve the quality and efficiency of breast cancer screening. Transpara is currently used in over 200 clinics in 25 countries worldwide.

Insight Partners is a US-based venture capital and private equity firm with more than US$30 billion in capital commitments. With its experience and track record of investing in high-growth technology and software companies that drive transformative change in their industries, Insight Partners is ideally situated to support ScreenPoint Medical with its endeavors. Alongside Insight Partners, University Radiology Group, one of the largest providers of sub-specialty radiology and teleradiology services in the United States, participated in the investment round. Existing investors, including ScreenPoint Medical’s founders Siemens Healthineers and Oost NL, will continue to support the company in its further growth and development.

Oaklins’ team in the Netherlands acted as the exclusive advisor to the shareholders and management of ScreenPoint Medical.

About ScreenPoint

ScreenPoint was founded in 2014 as a spin-off from Radboud University Medical Center in Nijmegen, the Netherlands, to develop and bring to market innovative machine learning solutions to improve breast cancer screening and diagnosis. With an exceptional team of specialists in machine learning, image analysis and breast imaging, ScreenPoint developed the market-leading AI solution Transpara for reading mammograms and breast tomosynthesis.

About Insight Partners

Insight Partners is a leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies that are driving transformative change in their industries. Founded in 1995, Insight Partners has invested in more than 400 companies worldwide and has raised through a series of funds more than US$30 billion in capital commitments. Insight's mission is to find, fund and work successfully with visionary executives, providing them with practical, hands-on software expertise to foster long-term success. Across its people and its portfolio, Insight encourages a culture around a belief that ScaleUp companies and growth create opportunity for all.

Service
Funding, debt advisory & ECM
Parties
“We are delighted to welcome Insight Partners as a new shareholder of ScreenPoint Medical. Their broad experience and network within the medical technology sector will enable us to further develop and commercialize our AI solution. The support and guidance of the Oaklins team, together with their experience in the medical imaging space, has proven extremely valuable throughout this process.”

Nico Karssemeijer

Founder and CEO

Talk to the deal team

 Robert  Boersma

Robert Boersma

Partner

Amsterdam, Netherlands
Oaklins Netherlands
 Martijn  de Win

Martijn de Win

Associate Director

Amsterdam, Netherlands
Oaklins Netherlands
 Robbert  Bon

Robbert Bon

Associate

Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Garz & Fricke Group has been acquired by SECO S.p.A
Private Equity | TMT

Garz & Fricke Group has been acquired by SECO S.p.A

SECO S.p.A., a reference player in the field of technological innovation, Internet of Things and Artificial Intelligence solutions, listed on the STAR segment of Italian Stock Exchange (Ticker: IOT:MI), has entered into an agreement to acquire the 100% of the shares of Garz&Fricke Holding GmbH (G&F), a Hamburg-based producer and developer of hardware and software solutions for industrial IoT, from the financial investor Afinum Management GmbH and other minority shareholders.

Learn more
Cerion Solutions has been acquired by Netum Group
TMT

Cerion Solutions has been acquired by Netum Group

Cerion Oy has sold Cerion Solutions Oy to the publicly listed company Netum Group Oyj.

Learn more
East West Eye Institute has been acquired by NVISION Eye Centers
Healthcare

East West Eye Institute has been acquired by NVISION Eye Centers

East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, has sold a majority interest to Nvision Eye Centers, one of the larger providers of comprehensive eyecare, LASIK and cataract surgery services in the USA.

Learn more